Reinwald H
Medizïnische Klinik, Caritas-Krankenhauses Bad Mergentheim.
Med Klin (Munich). 1997 Nov 15;92(11):663-74. doi: 10.1007/BF03044823.
During the past decade, the diagnostic technologies concerning the hepatocellular carcinoma have been enriched by the vascular doppler ultrasound, the ultrasound echo-enhancing agents and the magnetic resonance tomography. The therapeutic possibilities have been augmented by the percutaneous ethanol instillation therapy, the combination of local therapies with transcatheter arterial embolisation and the more effective after-treatment after transplantation and segment resection. The use of the respective treatment modalities depends on the tumor constellation, the functional liver reserve, the patients general condition and the risk/benefit ratio of the treatment. The quality of life should be optimized because of the poor tumor prognosis. As there have been no real advances in the treatment of hepatocellular carcinoma to date, the prevention and early diagnosis of the tumor in high risk populations is of utmost importance.
在过去十年中,有关肝细胞癌的诊断技术因血管多普勒超声、超声造影剂和磁共振断层扫描而更加丰富。经皮乙醇注射疗法、局部治疗与经导管动脉栓塞术的联合应用以及移植和节段切除术后更有效的后续治疗增加了治疗的可能性。各种治疗方式的使用取决于肿瘤情况、肝脏功能储备、患者的一般状况以及治疗的风险/获益比。鉴于肿瘤预后较差,应优化生活质量。由于迄今为止肝细胞癌的治疗尚无实质性进展,高危人群中肿瘤的预防和早期诊断至关重要。